News & Articles

Launch supports World Health Organization’s strategic plan for the elimination of life-threatening neglected tropical disease

Preliminary results show 92% sensitivity and 100% specificity, compared with RT-PCR

BotrytisAlert harnesses Mologic’s expert lateral flow technology to enable earlier disease intervention and prevent wide-spread crop failures

The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes

The testing capability of Mologic's kits is expected to relieve immediate testing pressures in the UK and Africa

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis

The novel diagnostics device delivers up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts of global epidemics

Study will evaluate urinary biomarkers associated with onset of pulmonary exacerbations and validate HeadsUp POC diagnostic for patient self-monitoring

The test will expand the range of diagnostic options available to guide the treatment of Plasmodium vivax

Newly launched point-of-care test detects biomarkers of infection using lateral flow immunoassay